Sobre 32 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the full record of transactions filed by Patel Snehal, Presidente y Director General. Insider active across 1 company, notably Greenwich LifeSciences, Inc.. In total, 81 reports have been logged. Split: 81 buys · 0 sell. Total volume traded: €5.9m. Activity tracked since 14 December 2021. The latest transaction was filed on 29 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Patel Snehal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2000 títulos@ 13,81 US$0.5% de su flujoCommon StockSEC:0001493152-24-030637:0
Salida canónica: 4 nov 2024 (T+90)
25 de 81 declaraciones
About Patel Snehal
Patel Snehal is Chief Financial Officer and Chief Executive Officer at Greenwich LifeSciences, Inc. He has 76 filings in total, and in the sampled recent filings, all transactions are acquisitions, with total खरीद? Wait no French/English should be English. Need remove buy typo. Let's craft.